Vicarious Surgical Inc.
RBOT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.06 | -0.06 | 0.08 |
| FCF Yield | -32.20% | -30.29% | -30.29% | -15.38% |
| EV / EBITDA | -3.96 | -4.11 | -3.24 | -6.12 |
| Quality | ||||
| ROIC | -41.79% | -36.44% | -32.49% | -24.45% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.94 | 1.02 | 0.76 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 21.90% | -14.60% | 1.63% | 5.56% |
| Safety | ||||
| Net Debt / EBITDA | -0.91 | -0.71 | -0.71 | -0.30 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -233.95 | 0.00 | 0.00 | -193.62 |